Matches in Nanopublications for { ?s ?p "[In two MET-amplified human gastric tumor xenograft models, SNU-5 and Hs 746T, intravenous treatment with SAR125844 leads to potent, dose- and time-dependent inhibition of the MET kinase and to significant impact on downstream PI3K/AKT and RAS/MAPK pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[In two MET-amplified human gastric tumor xenograft models, SNU-5 and Hs 746T, intravenous treatment with SAR125844 leads to potent, dose- and time-dependent inhibition of the MET kinase and to significant impact on downstream PI3K/AKT and RAS/MAPK pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1248067.RAHEUU3JechkxJY67P2LzZMMKn9qu8XkBdxxsb_Cy4ELY130_assertion description "[In two MET-amplified human gastric tumor xenograft models, SNU-5 and Hs 746T, intravenous treatment with SAR125844 leads to potent, dose- and time-dependent inhibition of the MET kinase and to significant impact on downstream PI3K/AKT and RAS/MAPK pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248067.RAHEUU3JechkxJY67P2LzZMMKn9qu8XkBdxxsb_Cy4ELY130_provenance.
- NP1248061.RAw06ZfIkJtmxPBMkIXRT2psbqI3Wd-UnZRIRZkWnVm8k130_assertion description "[In two MET-amplified human gastric tumor xenograft models, SNU-5 and Hs 746T, intravenous treatment with SAR125844 leads to potent, dose- and time-dependent inhibition of the MET kinase and to significant impact on downstream PI3K/AKT and RAS/MAPK pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248061.RAw06ZfIkJtmxPBMkIXRT2psbqI3Wd-UnZRIRZkWnVm8k130_provenance.
- NP1248064.RA5S6sl-2G2PMtYFA5n0ttwAnh8wLcZdq4eTlV6dUA7UU130_assertion description "[In two MET-amplified human gastric tumor xenograft models, SNU-5 and Hs 746T, intravenous treatment with SAR125844 leads to potent, dose- and time-dependent inhibition of the MET kinase and to significant impact on downstream PI3K/AKT and RAS/MAPK pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248064.RA5S6sl-2G2PMtYFA5n0ttwAnh8wLcZdq4eTlV6dUA7UU130_provenance.
- NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion description "[In two MET-amplified human gastric tumor xenograft models, SNU-5 and Hs 746T, intravenous treatment with SAR125844 leads to potent, dose- and time-dependent inhibition of the MET kinase and to significant impact on downstream PI3K/AKT and RAS/MAPK pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.